When Patience Gets Policy Support: A New Chapter for India’s Startups
Share only for educational purposes — Not stock tips or investment advice.
This is original learning content, aligned with SEBI (Research Analysts) Regulations, 2013.
India is encouraging long-term innovation by expanding startup eligibility and giving deep-tech companies time, scale, and patient capital.
Imagine building something that takes 10–15 years before it earns real money—like a semiconductor chip, a new drug, or advanced AI hardware.
Earlier, many such startups outgrew policy support before they matured.
The government’s revised Startup India framework changes this story.
The turnover limit for startup recognition is now ₹200 crore, giving growing companies more breathing room. More importantly, a dedicated Deep Tech Startup category has been created, with a ₹300 crore turnover cap and a 20-year eligibility window—double the usual period.
This signals one clear intent:
👉 India wants to support research-heavy, slow-gestation innovation, not just quick-revenue startups.
For markets, this matters because patient capital, public R&D spending, and private partnerships often flow through listed companies that supply technology, manufacturing, pharma research, digital infrastructure, and electronics.
Tata Consultancy Services – AI, platforms, and enterprise R&D services
Infosys – Deep tech partnerships, digital engineering
HCL Technologies